Prophylactic breast irradiation with a single dose of electron beam radiotherapy (10 Gy) significantly reduces the incidence of bicalutamide-induced gynecomastia

International Journal of Radiation Oncology Biology Physics

Volumn 60, Issue 2, 2004, Pages 476-483

  Tyrrell, Christopher J ^a,l   Payne, Heather ^b   Tammela, Teuvo L J ^c   Bakke, August ^d   Lodding, Pär ^e   Goedhals, Louis ^f   Van Erps, Peter ^g   Boon, Tom ^h   Van De Beek, Cees ⁱ   Andersson, Swen Olof ^j   Morris, Tom ^k   Carroll, Kevin ^k  

^a Plymouth Oncology Centre   (United Kingdom)

^b MIDDLESEX HOSPITAL   (United Kingdom)

^c TAMPERE UNIVERSITY HOSPITAL   (Finland)

^d HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^e SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^f National Hospital Bloemfontein   (South Africa)

^g ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^h UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

ⁱ MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^j ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^k ASTRAZENECA   (United Kingdom)

^l DERRIFORD HOSPITAL   (United Kingdom)

more..

Author keywords

Bicalutamide; Breast irradiation; Breast pain; Gynecomastia; Prophylactic radiotherapy

Indexed keywords

DISEASES; DRUG DOSAGE; ELECTRON BEAMS; PATIENT MONITORING; RADIOTHERAPY;

BREAST IRRADIATION; ELECTRON BEAM RADIOTHERAPY; PROSTATE CANCER;

DOSIMETRY;

BICALUTAMIDE;

ABDOMINAL PAIN; ADULT; AGED; ANEMIA; ARTICLE; ASTHENIA; BACKACHE; BREAST TENDERNESS; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DIZZINESS; DYSURIA; ELECTRON BEAM; ERYTHEMA; GOUT; GYNECOMASTIA; HEART INFARCTION; HEMATURIA; HUMAN; IMPOTENCE; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MASTALGIA; PELVIS PAIN SYNDROME; PERIPHERAL EDEMA; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROSTATE CANCER; PRURITUS; RADIATION RESPONSE; RASH; RISK; SKIN DISCOLORATION; SKIN IRRITATION; URINARY FREQUENCY; URINARY TRACT DISEASE; URINARY TRACT INFECTION; URINARY URGENCY; URINE RETENTION; VASODILATATION;

AGED; AGED, 80 AND OVER; ANDROGEN ANTAGONISTS; ANILIDES; BREAST; BREAST DISEASES; CONFIDENCE INTERVALS; DOUBLE-BLIND METHOD; ELECTRONS; GYNECOMASTIA; HUMANS; MALE; MIDDLE AGED; PAIN; PROSTATIC NEOPLASMS;

EID: 4544365329     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2004.03.022     Document Type: Article

References (21)

1. Wilson J.D., Aiman J., MacDonald P.C. The pathogenesis of gynecomastia. Adv Intern Med. 25:1980;1-32
2. Mathur R., Braunstein G.D. Gynecomastia pathomechanisms and treatment strategies. Horm Res. 48:1997;95-102
3. Iversen P., Tyrrell C.J., Kaisary A.V., et al. Bicalutamide monotherapy compared with castration in patients with nonmetastatic locally advanced prostate cancer 6.3 years of followup. J Urol. 164:2000;1579-1582
4. Boccon-Gibod L., Fournier G., Bottet P., et al. Flutamide versus orchidectomy in the treatment of metastatic prostate carcinoma. Eur Urol. 32:1997;391-395
5. Oosterlinck W., Casselman J., Mattelaer J., et al. Tolerability and safety of flutamide in monotherapy, with orchiectomy or with LHRH-a in advanced prostate cancer patients. A Belgian multicenter study of 905 patients. Eur Urol. 30:1996;458-463
6. Chang A., Yeap B., Davis T., et al. Double-blind, randomized study of primary hormonal treatment of stage D2 prostate carcinoma flutamide versus diethylstilbestrol. J Clin Oncol. 14:1996;2250-2257
7. Robinson M.R., Smith P.H., Richards B., et al. The final analysis of the EORTC Genito-Urinary Tract Cancer Co-Operative Group phase III clinical trial (protocol 30805) comparing orchidectomy, orchidectomy plus cyproterone acetate and low dose stilboestrol in the management of metastatic carcinoma of the prostate. Eur Urol. 28:1995;273-283
8. Decensi A.U., Boccardo F., Guarneri D., et al. Monotherapy with nilutamide, a pure nonsteroidal antiandrogen, in untreated patients with metastatic carcinoma of the prostate. The Italian Prostatic Cancer Project. J Urol. 146:1991;377-381
9. Pavone-Macaluso M., de Voogt H.J., Viggiano G., et al. Comparison of diethylstilbestrol, cyproterone acetate and medroxyprogesterone acetate in the treatment of advanced prostatic cancer Final analysis of a randomized phase III trial of the European Organization for Research on Treatment of Cancer Urological Group. J Urol. 136:1986;624-631
10. See W.A., Wirth M.P., McLeod D.G., et al. Bicalutamide as immediate therapy either alone or as adjuvant to standard care of patients with localized or locally advanced prostate cancer First analysis of the early prostate cancer program. J Urol. 168:2002;429-435
11. Fass D., Steinfeld A., Brown J., et al. Radiotherapeutic prophylaxis of estrogen-induced gynecomastia A study of late sequela. Int J Radiat Oncol Biol Phys. 12:1986;407-408
12. Gagnon J.D., Moss W.T., Stevens K.R. Pre-estrogen breast irradiation for patients with carcinoma of the prostate A critical review. J Urol. 121:1979;182-184
13. Corvalan J.G., Gill W.M. Jr, Egleston T.A., et al. Irradiation of the male breast to prevent hormone produced gynecomastia. Am J Roentgenol Radium Ther Nucl Med. 106:1969;839-840
14. Alfthan O., Holsti L.R. Prevention of gynecomastia by local roentgen irradiation in estrogen-treated prostatic carcinoma. Scand J Urol Nephrol. 3:1969;183-187
15. Waterfall N.B., Glaser M.G. A study of the effects of radiation on prevention of gynaecomastia due to oestrogen therapy. Clin Oncol. 5:1979;257-260
16. Widmark A., Fossa S.D., Lundmo P., et al. Does prophylactic breast irradiation prevent antiandrogen-induced gynecomastia? Evaluation of 253 patients in the randomized Scandinavian trial SPCG-7/SFUO-3. Urology. 61:2003;145-151
17. Thames H.D., Bentzen S.M., Turesson I., et al. Fractionation parameters for human tissues and tumors. Int J Radiat Biol. 56:1989;701-710
18. Joiner M.C. The linear-quadratic approach to fractionation. Steel G.G. Basic clinical radiobiology. 1993;55-64 Edward Arnold, London
19. Williams M.J. Gynaecomastia. Its incidence, recognition and host characterisation in 447 autopsy cases. Am J Med. 34:1963;103-112
20. Van Poppel H, Tyrrell CJ, Van Cangh P, et al. Efficacy and tolerability of radiotherapy as a treatment for bicalutamide-induced breast pain and gynaecomastia in prostate cancer. Poster presented at ECCO-12, Copenhagen, Denmark, 21-25 September 2003
21. Abson C. Radiotherapy for benign diseases. Br J Radiol. 73:2000;121-122